167 related articles for article (PubMed ID: 24206042)
41. Cytokine profiles of healthy and diseased sites in individuals with periodontitis.
Miranda TS; Figueiredo NF; Figueiredo LC; Silva HDPD; Rocha FRG; Duarte PM
Arch Oral Biol; 2020 Dec; 120():104957. PubMed ID: 33129128
[TBL] [Abstract][Full Text] [Related]
42. LPS-induced inflammatory response after therapy of aggressive periodontitis.
Shaddox LM; Gonçalves PF; Vovk A; Allin N; Huang H; Hou W; Aukhil I; Wallet SM
J Dent Res; 2013 Aug; 92(8):702-8. PubMed ID: 23788609
[TBL] [Abstract][Full Text] [Related]
43. Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors.
Santos VR; Ribeiro FV; Lima JA; Miranda TS; Feres M; Bastos MF; Duarte PM
J Periodontal Res; 2012 Feb; 47(1):45-54. PubMed ID: 21806617
[TBL] [Abstract][Full Text] [Related]
44. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1beta and prostaglandin E(2) among non-smoking subjects with gingivitis and type 2 diabetes.
Andriankaja OM; Barros SP; Moss K; Panagakos FS; DeVizio W; Beck J; Offenbacher S
J Periodontol; 2009 Feb; 80(2):307-16. PubMed ID: 19186972
[TBL] [Abstract][Full Text] [Related]
45. Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients.
Bıyıkoğlu B; Buduneli N; Aksu K; Nalbantsoy A; Lappin DF; Evrenosoğlu E; Kinane DF
Rheumatol Int; 2013 Oct; 33(10):2607-16. PubMed ID: 23728274
[TBL] [Abstract][Full Text] [Related]
46. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis.
Kardeşler L; Buduneli N; Cetinkalp S; Kinane DF
J Periodontol; 2010 Jan; 81(1):24-33. PubMed ID: 20059414
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of Clinical Parameters and Levels of Proinflammatory Cytokines in the Crevicular Fluid Around Dental Implants in Patients with Type 2 Diabetes Mellitus.
Dŏgan ŞB; Kurtiş MB; Tüter G; Serdar M; Watanabe K; Karakış S
Int J Oral Maxillofac Implants; 2015; 30(5):1119-27. PubMed ID: 26394349
[TBL] [Abstract][Full Text] [Related]
48. The correlation of serum and gingival crevicular fluid cytokines in obese subjects.
Fell RA; Zee KY; Arora M
J Int Acad Periodontol; 2013 Jan; 15(1):20-8. PubMed ID: 23413628
[TBL] [Abstract][Full Text] [Related]
49. Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
Keles ZP; Keles GC; Avci B; Cetinkaya BO; Emingil G
J Periodontol; 2014 Sep; 85(9):1240-6. PubMed ID: 24635545
[TBL] [Abstract][Full Text] [Related]
50. Short-term effects of non-surgical periodontal treatment on the gingival crevicular fluid cytokine profiles in sites with induced periodontal defects: a study on dogs with and without streptozotocin-induced diabetes.
Javed F; Al-Daghri NM; Wang HL; Wang CY; Al-Hezaimi K
J Periodontol; 2014 Nov; 85(11):1589-95. PubMed ID: 24835413
[TBL] [Abstract][Full Text] [Related]
51. Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment.
Fentoğlu O; Kirzioğlu FY; Ozdem M; Koçak H; Sütçü R; Sert T
Oral Dis; 2012 Apr; 18(3):299-306. PubMed ID: 22151458
[TBL] [Abstract][Full Text] [Related]
52. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
Salvi GE; Beck JD; Offenbacher S
Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of Endocan and Tumor Necrosis Factor-α as Inflammatory Biomarkers in Type 2 Diabetes and Periodontal Disease.
Kumar G; Ponnaiyan D; Parthasarathy H; Tadepalli A; Veeramani S
Genet Test Mol Biomarkers; 2020 Jul; 24(7):431-435. PubMed ID: 32513032
[No Abstract] [Full Text] [Related]
54. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics.
Kardeşler L; Biyikoğlu B; Cetinkalp S; Pitkala M; Sorsa T; Buduneli N
Oral Dis; 2010 Jul; 16(5):476-81. PubMed ID: 20233316
[TBL] [Abstract][Full Text] [Related]
55. Gingival crevicular fluid levels of protease-activated receptors type 1 and type 2 in diabetic patients with periodontitis.
Abreu IS; Euzebio Alves VT; Benedete AP; Bueno da Silva HA; França BN; Saraiva L; Lima LA; Carvalho MH; Holzhausen M
J Periodontal Res; 2016 Oct; 51(5):577-85. PubMed ID: 26564991
[TBL] [Abstract][Full Text] [Related]
56. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment.
Gamonal J; Acevedo A; Bascones A; Jorge O; Silva A
J Periodontol; 2000 Oct; 71(10):1535-45. PubMed ID: 11063385
[TBL] [Abstract][Full Text] [Related]
57. Cytokine profile in the gingival crevicular fluid of periodontitis patients with and without type 2 diabetes: a literature review.
Javed F; Al-Askar M; Al-Hezaimi K
J Periodontol; 2012 Feb; 83(2):156-61. PubMed ID: 21692634
[TBL] [Abstract][Full Text] [Related]
58. Effects of Systemic Simvastatin on the Concentrations of Visfatin, Tumor Necrosis Factor-
Bahammam MA; Attia MS
J Immunol Res; 2018; 2018():8481735. PubMed ID: 30186882
[TBL] [Abstract][Full Text] [Related]
59. Effects of statins on cytokines levels in gingival crevicular fluid and saliva and on clinical periodontal parameters of middle-aged and elderly patients with type 2 diabetes mellitus.
Zhang H; Zhang Y; Chen X; Li J; Zhang Z; Yu H
PLoS One; 2021; 16(1):e0244806. PubMed ID: 33417619
[TBL] [Abstract][Full Text] [Related]
60. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes.
Correa FO; Gonçalves D; Figueredo CM; Bastos AS; Gustafsson A; Orrico SR
J Clin Periodontol; 2010 Jan; 37(1):53-8. PubMed ID: 19968741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
